SCHEMBL19904683

SCHEMBL19904683

CCCNCCCc1ccc(OC2CC2)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.38
SKP2 Q13309 1/20 0.37
RECQL P46063 2/20 0.37
S1PR2 O95136 2/20 0.37
S1PR1 P21453 2/20 0.37
S1PR3 Q99500 2/20 0.37
LPAR2 Q9HBW0 1/20 0.37
GAA P10253 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
HTR1A P08908 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9845132 0.81 SIGMAR1 (0.49) SIGMAR1RECQLMEN1KMT2AALDH1A1
SCHEMBL19904450 0.81 MEN1 (0.39) RECQLS1PR2S1PR1S1PR3GAA
SCHEMBL18634962 0.78 ALDH1A1 (0.40) SKP2RECQLGAAMEN1KMT2A
SCHEMBL9845102 0.76 RECQL (0.49) SIGMAR1RECQLGAAMEN1KMT2A
SCHEMBL19904403 0.76 ALDH1A1 (0.36) SKP2RECQLS1PR1GAAMEN1
SCHEMBL9845131 0.76 RECQL (0.52) SIGMAR1RECQLGAAMEN1KMT2A
SCHEMBL9845125 0.75 RECQL (0.51) SIGMAR1RECQLGAAMEN1KMT2A
SCHEMBL22673091 0.74 SKP2 (0.36) SIGMAR1SKP2S1PR2S1PR1S1PR3
SCHEMBL24045454 0.74 HRH1 (0.47) SIGMAR1RECQLALDH1A1DRD2
SCHEMBL21122862 0.74 ABCB1 (0.46) SIGMAR1RECQLALDH1A1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed